Expects Strong Fourth Quarter 2016 Results
Preliminary 2017 Guidance Within Range of Analysts’ Average Expectations
Company Revises 2016 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)--PharMerica Corporation (the “Corporation” or the “Company”) (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the third quarter ended September 30, 2016.
“In summary, we expect to resume our growth trend in the fourth quarter of this year, and this growth will propel earnings momentum into 2017. We remain confident that the Company’s business diversification and growth strategies will support long-term growth in earnings and shareholder value.”
